TELCON RF PHARMACEUTICAL. Inc. (KOSDAQ: 200230)
South Korea
· Delayed Price · Currency is KRW 5,980.00
0.00 (0.00%)
Dec 9, 2024, 9:00 AM KST
TELCON RF PHARMACEUTICAL. Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 36,951 | 36,307 | 27,830 | 37,841 | 33,141 | 56,591 | Upgrade
|
| Other Revenue | - | -0 | - | -0 | - | - | Upgrade
|
| Revenue | 36,951 | 36,307 | 27,830 | 37,841 | 33,141 | 56,591 | Upgrade
|
| Revenue Growth (YoY) | 12.50% | 30.46% | -26.46% | 14.18% | -41.44% | -1.94% | Upgrade
|
| Cost of Revenue | 27,876 | 26,800 | 22,267 | 28,780 | 25,905 | 41,499 | Upgrade
|
| Gross Profit | 9,075 | 9,507 | 5,563 | 9,061 | 7,236 | 15,092 | Upgrade
|
| Selling, General & Admin | 5,791 | 4,484 | 4,554 | 6,949 | 7,391 | 4,425 | Upgrade
|
| Research & Development | 733.17 | 733.17 | 1,208 | 1,635 | 1,817 | 1,710 | Upgrade
|
| Other Operating Expenses | 61.26 | 59.76 | 68.03 | 168.3 | 53.62 | 83.93 | Upgrade
|
| Operating Expenses | 9,784 | 8,542 | 9,626 | 13,624 | 9,326 | 12,146 | Upgrade
|
| Operating Income | -708.58 | 965.32 | -4,063 | -4,563 | -2,090 | 2,946 | Upgrade
|
| Interest Expense | -2,312 | -603.58 | -1,063 | -7,702 | -2,849 | -1,835 | Upgrade
|
| Interest & Investment Income | 301.08 | 205.05 | 61.42 | 45.48 | 57.21 | 56.46 | Upgrade
|
| Earnings From Equity Investments | -9,286 | 469.53 | -17,868 | -13,196 | -39,204 | -20,556 | Upgrade
|
| Currency Exchange Gain (Loss) | 211.32 | 119.08 | 318.02 | 831.71 | 178.36 | 251.83 | Upgrade
|
| Other Non Operating Income (Expenses) | 961.5 | -837.92 | -1,981 | 77.32 | -135.85 | 204.18 | Upgrade
|
| EBT Excluding Unusual Items | -10,833 | 317.48 | -24,595 | -24,507 | -44,042 | -18,933 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | -4,179 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 617.31 | 13,466 | -13,146 | 4,626 | 9,010 | -25,196 | Upgrade
|
| Gain (Loss) on Sale of Assets | 18.47 | -14.8 | 34.38 | 10.31 | -179.33 | -166.96 | Upgrade
|
| Asset Writedown | -229.06 | -64.8 | -4,411 | -3,005 | -51.13 | -10,666 | Upgrade
|
| Other Unusual Items | 336.83 | 244.63 | - | - | -2,209 | - | Upgrade
|
| Pretax Income | -10,089 | 13,949 | -42,117 | -22,875 | -41,652 | -54,961 | Upgrade
|
| Income Tax Expense | - | - | - | - | 18.95 | 0.33 | Upgrade
|
| Earnings From Continuing Operations | -10,089 | 13,949 | -42,117 | -22,875 | -41,671 | -54,962 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | -331.42 | -355.73 | - | Upgrade
|
| Net Income to Company | -10,089 | 13,949 | -42,117 | -23,207 | -42,027 | -54,962 | Upgrade
|
| Minority Interest in Earnings | 41.54 | -42.34 | 32.81 | 108.8 | 1,134 | 151.94 | Upgrade
|
| Net Income | -10,048 | 13,906 | -42,084 | -23,098 | -40,893 | -54,810 | Upgrade
|
| Net Income to Common | -10,048 | 13,906 | -42,084 | -23,098 | -40,893 | -54,810 | Upgrade
|
| Shares Outstanding (Basic) | 12 | 11 | 11 | 9 | 9 | 8 | Upgrade
|
| Shares Outstanding (Diluted) | 12 | 15 | 14 | 9 | 9 | 8 | Upgrade
|
| Shares Change (YoY) | -17.91% | 8.89% | 56.33% | 2.64% | 3.29% | 7.53% | Upgrade
|
| EPS (Basic) | -862.34 | 1243.94 | -3967.18 | -2629.30 | -4778.04 | -6615.15 | Upgrade
|
| EPS (Diluted) | -862.34 | 1025.12 | -3967.18 | -2629.30 | -4781.56 | -6693.51 | Upgrade
|
| Free Cash Flow | -2,662 | -4,954 | -2,912 | -2,613 | 1,671 | 4,056 | Upgrade
|
| Free Cash Flow Per Share | -228.49 | -331.29 | -212.07 | -297.40 | 195.25 | 489.48 | Upgrade
|
| Gross Margin | 24.56% | 26.19% | 19.99% | 23.95% | 21.83% | 26.67% | Upgrade
|
| Operating Margin | -1.92% | 2.66% | -14.60% | -12.06% | -6.31% | 5.21% | Upgrade
|
| Profit Margin | -27.19% | 38.30% | -151.22% | -61.04% | -123.39% | -96.85% | Upgrade
|
| Free Cash Flow Margin | -7.21% | -13.65% | -10.46% | -6.90% | 5.04% | 7.17% | Upgrade
|
| EBITDA | 3,676 | 5,210 | 218.47 | -363.07 | 2,307 | 7,378 | Upgrade
|
| EBITDA Margin | 9.95% | 14.35% | 0.79% | -0.96% | 6.96% | 13.04% | Upgrade
|
| D&A For EBITDA | 4,385 | 4,244 | 4,281 | 4,200 | 4,397 | 4,432 | Upgrade
|
| EBIT | -708.58 | 965.32 | -4,063 | -4,563 | -2,090 | 2,946 | Upgrade
|
| EBIT Margin | -1.92% | 2.66% | -14.60% | -12.06% | -6.31% | 5.21% | Upgrade
|
| Advertising Expenses | - | 10.77 | 45.18 | 3.36 | 18.62 | 157.13 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.